Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

 655.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 682.00
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 120.54m
  • Volume: 0
  • Market Cap: £789.53m
  • RiskGrade: 125
  • Beta: 1.78

Latest ShareCast News

Total Voting Rights

By Sharecast

Date: Friday 02 Jan 2026

OXB ShareCast News

Block Listing Return 02-Jan-2026 ShareCast
Oxford Biomedica acquires US viral vector facility 07-Oct-2025 ShareCast
Oxford Biomedica reiterates outlook as interim l... 23-Sep-2025 ShareCast
RBC Capital Markets raises target price on OXB 26-Aug-2025 ShareCast
Oxford Biomedica raises £60m to bolster US capac... 15-Aug-2025 ShareCast

OXB Regulatory News

Total Voting Rights 02-Jan-2026 07:00 RNS
Block Listing Return 02-Jan-2026 07:00 RNS
Block Listing Return 02-Jan-2026 07:00 RNS
Total Voting Rights 02-Jan-2026 07:00 RNS
PDMR Dealing 08-Dec-2025 15:15 RNS

OXB Newspaper Links

Need to know: Opec cuts forecast ... Tesco cuts ... 16-Aug-2008 Times
Need to know 10-May-2008 Times
DSG International may be losing its spark 12-Feb-2008 Telegraph
Oxford BioMedica clinches $690m licensing deal f... 29-Mar-2007 The Independent
Oxford Biomedica seals €518m deal with Sanofi ov... 29-Mar-2007 Times

OXB Tips & Analysis

FTSE 100 latest: Oil falls take shares lower 06-Jul-2009 Daily Mail
The Investment Column: Oxford Biomedica 11-Mar-2008 The Independent
Jetion could benefit from Spanish election 11-Mar-2008 Times
The Week Ahead: Kazakh and Tate & Lyle head for ... 10-Mar-2008 The Independent
Market Report: Prudential driven up on Chinese b... 06-Mar-2008 The Independent

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 655.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 682.00
52 Week Low 232.50
Volume 0
Shares Issued 120.54m
Market Cap £789.53m
Beta 1.78
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 3
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page